Evidence map›Paper›PMID 20724440›Full record

ArticleNucleic acids research2010

Building promoter aware transcriptional regulatory networks using siRNA perturbation and deepCAGE.

Morana Vitezic, Timo Lassmann, Alistair R R Forrest, Masanori Suzuki, Yasuhiro Tomaru, Jun Kawai, Piero Carninci, Harukazu Suzuki, Yoshihide Hayashizaki, Carsten O Daub

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 19 citations in OpenAlex.

  1. Single-cell RNA sequencing uncovers the nuclear decoy lincRNA PIRAT as a regulator of systemic monocyte immunity during COVID-19.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Morana VitezicOmics Science Center, RIKEN Yokohama Institute, 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama 230-0045, Japan. mvitezic@gsc.riken.jp
Timo Lassmann
Alistair R R Forrest
Masanori Suzuki
Yasuhiro Tomaru
Jun Kawai
Piero Carninci
Harukazu Suzuki
Yoshihide Hayashizaki
Carsten O Daub
RIKEN Center for Integrative Medical Sciences · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Perturbation and time-course data sets, in combination with computational approaches, can be used to infer transcriptional regulatory networks which ultimately govern the developmental pathways and responses of cells. Here, we individually knocked down the four transcription factors PU.1, IRF8, MYB and SP1 in the human monocyte leukemia THP-1 cell line and profiled the genome-wide transcriptional response of individual transcription starting sites using deep sequencing based Cap Analysis of Gene Expression. From the proximal promoter regions of the responding transcription starting sites, we derived de novo binding-site motifs, characterized their biological function and constructed a network. We found a previously described composite motif for PU.1 and IRF8 that explains the overlapping set of transcriptional responses upon knockdown of either factor.

Indexed as

Gene Regulatory NetworksPromoter Regions, GeneticTranscription, GeneticBinding SitesCell Line, TumorGene Expression ProfilingGene Knockdown TechniquesHumansInterferon Regulatory Factor-8Interferon Regulatory FactorsOligonucleotide Array Sequence AnalysisProto-Oncogene ProteinsProto-Oncogene Protein Spi-1RNA, Small InterferingSequence Analysis, DNATrans-ActivatorsInterferon Regulatory Factor-8Interferon Regulatory FactorsProto-Oncogene ProteinsProto-Oncogene Protein Spi-1RNA, Small InterferingTrans-ActivatorsTranscription Factors

Identifiers

PMID20724440
PMCPMC3001087
OpenAlexW1979926492

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.